Hepatobiliary Surgery and Nutrition

Papers
(The TQCC of Hepatobiliary Surgery and Nutrition is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Reply to: The letter to the editor “More details are needed about the use of multicenter propensity score matching analysis” by Feng et al.142
Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers109
Neoadjuvant therapy for resectable pancreatic cancers75
Does a patient who needs portal vein embolization (PVE) to proceed to major hepatectomy (MH) have the same hepatic functional reserve than a patient with no preoperative PVE?68
Can we talk about “futile surgery” for the upfront treatment of the perihilar cholangiocarcinoma?54
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma53
Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations43
Short postoperative hospital stay after pancreaticoduodenectomy: what is real minimally invasive surgery?36
Acute coil migration in upper gastrointestinal bleeding35
Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations35
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice29
Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience29
Surgical treatment of colorectal cancer liver metastases: individualized comprehensive treatment makes a difference28
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy27
Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases26
Loco-regional treatments of unresectable hepatocellular carcinoma: safety first23
Technical performance, surgical workload and patient outcomes of robotic and laparoscopic surgery for pediatric choledochal cyst: a multicenter retrospective cohort and propensity score-matched study22
Preoperative assessment of liver function and perioperative management of posthepatectomy liver failure22
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society Consensus Conference: towards better clinical care in transplant hepatology22
Innovations in liver organoids: the role of 3D bioprinting in creating functional organoids21
The limits of segmental dichotomy: rethinking how we classify and compare minimally invasive liver resections21
A 7-year-old girl with giant congenital biliary dilatation20
Comment on “Perihilar cholangiocarcinoma—novel benchmark values for surgical and oncological outcomes from 24 expert centers”20
Comment on: “Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study”18
Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular 18
Liver transplantation for hepatocellular carcinoma arising in non- cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China18
Addressing the malnutrition gap requires high-quality research, recognition of intervention complexity, and equitable implementation strategies17
Evolocumab induced short-term biliary stent blockage and acute cholangitis in a jaundice patient with pancreatic carcinoma: a rare complication of PCSK9 inhibitor17
The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma16
Robotic hepatectomy: challenge and progression16
Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection16
Construction and application of multicellular tumor microenvironment models based on three-dimensional bioprinting technology16
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent valid15
Guidelines for the management of pancreatic cystic lesions: many options, too few solutions?15
Dietitians’ role in obesity care: insights from the Academy of Nutrition and Dietetics15
Enhancing diagnostic strategies for biliary strictures: an evolving landscape15
Performance of major liver resection for gallbladder cancer—a western retrospective single center cohort study14
Rethinking resectability: the case for neoadjuvant treatment in resectable pancreatic cancer13
Editorial comment on: development and external validation of a model to predict overall survival in patients with resected gallbladder cancer13
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma13
Novel biomarkers for hepatocellular carcinoma detection and treatment13
Expert consensus on difficult airway assessment13
Does preoperative routine statin use reduce post-hepatectomy liver failure?—an international multicentre retrospective cohort study on 2,342 patients12
“One-day, one-stay, and one-step” lessons from the Danish guidelines for the treatment of gallstone disease12
Resection and yttrium-90 radioembolization as sequential downstaging to living donor liver transplantation for large, multifocal hepatocellular carcinoma with lobar portal vein tumor thrombosis11
Laparoscopic partial splenectomy in the treatment of splenic ectopic pregnancy11
Optimizing strategies to reduce alcohol consumption and relapses, improving abstinence in liver transplant recipients11
Association of a novel glycemic control index, time in range, with infectious complications after pancreatectomy11
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management11
Understanding drug-induced liver injury from the perspective of traditional Chinese medicine theory—Huohou theory of traditional Chinese medicine11
Thermal ablation in the curative treatment of colorectal liver metastasis: new standard of care?—lessons learned from the COLLISION trial10
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions10
Highlights of constructing liver-relevant in vitro models with 3D bioprinting10
Spontaneous regression of solid-pseudopapillary neoplasms with hepatic metastases10
Combination therapies for advanced hepatocellular carcinoma: a beacon of light or a castle in the air10
Trimming the fat myth: adipose tissue’s role in liver regeneration10
Impact of donor-recipient sex-matching patterns on liver transplantation outcomes: a cohort study based on United Network of Organ Sharing data9
Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients9
Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis9
Should all patients be offered liver venous deprivation for insufficient future liver remnant hypertrophy prior to major hepatectomy?9
Perioperative management of patients with liver cancer complicated with sarcopenia9
Robotic-assisted hepatopancreatoduodenectomy and resection of pancreatic tail for one multiple endocrine neoplasia type 1 secreting multiple hormones8
The 11th revision of the International Statistical Classification of Disease and Related Health Problems and Cholangiocarcinoma8
Minimally invasive hepatectomy is here to stay, but more evidence is needed8
Difficulties and opportunities of hospice care—the role of doctors8
Rules: abide or abandon?8
Construction of an intrahepatic portosystemic shunt using the magnetic compression technique: preliminary experiments in a canine model8
Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?8
Sengstaken-Blakemore tubes: a rescue system during liver transplantation8
Safety analysis of COVID-19 vaccines in liver transplant recipients: a two-center study8
De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial7
Confounders in developing a machine learning model for colorectal liver metastasis post-hepatectomy prognostications7
ALPPS versus portal vein embolization for hepatitis B virus-associated hepatocellular carcinoma: a delicate balance between volume and morbidity7
Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future7
Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives7
Alcohol-related liver disease7
“Winning” with laparoscopic liver resection for colorectal cancer liver metastases (CRLM)7
Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea7
Never change a winning team—liver stiffness measurement and platelet count as key surrogates for clinically significant portal hypertension7
Novel preoperative strategies to improve hepatocellular carcinoma resectability7
Application progress of spatial omics in hepatobiliary tumor research7
Development of scoring models to predict early pancreatic cancer risk in new-onset diabetes mellitus patients7
Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter 7
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future7
Screening for pancreatic cancer in individuals with genetic susceptibility7
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial7
Couinaud’s corrosion casts of the liver7
Ethical issues in innovative clinical research6
Feasibility and outcomes of robotic partial pancreatoduodenectomy6
De-escalating surgical treatment in low stage gallbladder cancer6
Risk predictors of post-hepatectomy liver failure: unraveling complexities and navigating challenges in clinical application6
Advancements and challenges in robotic donor hepatectomy: current evidence and unresolved questions6
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis6
Ectopic hepatocellular carcinoma of the abdominal wall6
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma6
Algorithm-based care for early recognition and management of complications after pancreatic resection: toward standardization of postoperative care6
Getting persuasive about the non-invasive: assessing liver fibrosis in practice—without a biopsy6
ESMO 2023 pancreatic cancer guidelines signal stepwise progress6
A systematic review of methodology in nutritional trials in patients undergoing pancreatoduodenectomy6
Acute cholecystitis in older adults with multimorbidity: does surgery offer better outcomes?6
Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention6
Surgical resection for pancreatic ductal adenocarcinoma with liver metastasis: is this the beginning of a new era?6
Laparoscopic duodenum-preserving pancreatic head resection guided by the two-stage indocyanine green fluorescence imaging6
To drain or not to drain after distal pancreatectomy: reflexions on the PANDORINA trial6
Evolution of systemic therapy for advanced-stage hepatocellular carcinoma6
A puzzling mixed cystic-solid mass at the hepatic hilum6
A new TNM T3 subclassification with corresponding prognostic stage grouping for gallbladder cancer: a multicenter retrospective study5
How will the latest modifications to the CG189 NICE guidelines for obesity management likely impact clinical care?5
Endothelial glycocalyx damage marker syndecan-1 during hypothermic oxygenated machine perfusion of donor grafts facilitates prediction of early allograft dysfunction after liver transplantation5
Can artificial intelligence deliver on the promise of precision medicine?5
EREG-secreting THBS1+ tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure5
The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma—unveiling the future challenges in drug therapy5
Early bifurcation of hepatic artery in right-sided living-donor hepatectomy at Asan Medical Center: rarely a critical issue5
Surgical treatment for neuroendocrine liver metastasis: moving ahead in controversy5
Non-invasive strategies to predict post-hepatectomy liver failure5
Can liver stiffness measurement accurately predict disease progression and clinical outcome in patients with metabolic dysfunction-associated steatotic liver disease and bridging fibrosis or cirrhosis5
How to deliver palliative care for patients with management in decompensated cirrhosis5
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions5
Surgical resection for hepatocellular carcinoma in cirrhotic patients with clinically significant portal hypertension: a multidisciplinary team decision5
Necessity of integrating statistical inference and clinical practice in developing clinical models: bias introduced by neoadjuvant chemotherapy5
The lymphatic vessels of the liver observed by Frederik Ruysch5
Utilization of hepatitis B virus-positive allografts in liver transplantation: a new arrow to the bowstring for expanding the donor pool?5
Comparative analysis of analgesic efficacy and functional recovery in open pancreaticoduodenectomy: a randomized controlled trial of local anesthetic wound infiltration, transversus abdominis plane bl5
Liver transplantation for non-resectable colorectal metastases—an evolving paradigm in transplant oncology5
Decision-making in high-risk leakage duodenopancreatectomy: pancreatic anastomosis or total pancreatectomy?5
In situ liver resection under venovenous bypass (LR-VVB) or venoarterial bypass (LR-VAB) adjunct to total vascular exclusion (TVE) as extreme liver surgery5
Rethinking portal hypertension in hepatocellular carcinoma resection: a gradient of risk beyond black and white5
Advanced pancreatic neuroendocrine neoplasia (pNEN): complex diseases with therapeutic challenges5
Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease5
Nutritional management guidelines for pancreatitis—a commentary5
Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg?4
Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer4
Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer4
Importance of an appropriate number of examined lymph nodes in patients with pancreatic cancer—the more the better?4
Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial4
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma4
Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases4
The impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on liver tumors with unusual indications4
The difficulty of medical decision-making: should patients be involved?4
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma4
An intriguing case of macrolides-induced pancreatic injury mimicking pancreatic carcinoma4
Short- and long-term outcomes and cost-effectiveness of robotic-assisted versus laparoscopic liver resection for Barcelona Clinic Liver Cancer (BCLC) 0/A hepatocellular carcinoma: a multicenter propen4
Hepatic “pregnancy”: hepatocellular carcinoma with extensive extrahepatic growth4
Exocrine pancreatic insufficiency: more compromise than precision4
Sex and age differences in the association between obesity and long-term changes with the risk of incident type 2 diabetes mellitus: the Rural Deqing Cohort Study4
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guide4
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review4
Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review3
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy3
Biliary sphincterotomy for sphincter of Oddi disorder: is sphincterotomy cutting it?3
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection3
Alternatives to left lateral segment for pediatric liver transplantation, or required surgeon toolkit?3
Modern surgical approach to hepatocellular carcinoma3
Is liver resection necessary for T2 gallbladder cancer?3
Advances in minimally invasive liver surgery: comparing robotic and laparoscopic approaches3
Machine learning-enhanced radiomics for predicting portal vein thrombectomy in liver transplantation3
Time to say goodbye: from Barcelona to Milan and the modern management of hepatocellular carcinoma3
Portal hypertensive biliopathy secondary to Abernethy malformation mimicking a hepatic hilum mass3
Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines3
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation3
“PUMC’s Three Treasures”: can their glory remain?3
Is immunotherapy-related liver injury more common in patients with hepatocellular carcinoma than in other advanced solid tumors?3
Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality3
Assessing the financial and equity implications of the 2020 liver allocation policy change3
The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease3
Ascites and complications: getting to the root of the trouble3
Impact of adjuvant therapy on survival outcomes in resected gallbladder cancer: a systematic review and meta-analysis3
Beyond precision: why time and human judgment still matter in the era of autonomous surgery3
Guidelines towards comprehensive care in acute pancreatitis3
Surgical techniques and tumor dissemination: a critical review of the CETUPANC trial on the superior mesenteric artery vs. no-touch approaches3
UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic UGT1A mice3
Utility of liver resection for breast cancer liver metastases, time for action3
A journey of a thousand miles begins with one small step3
Long- and short-term outcomes for resectable gallbladder carcinoma patients treated with curative-intent laparoscopic versus open resection: a multicenter propensity score-matched comparative study3
Liver venous deprivation (LVD) before extended hepatectomy: a French multicentric retrospective cohort3
High risk of thrombosis recurrence in people with idiopathic or only locally caused non-cirrhotic splanchnic vein thrombosis: it is time for guidelines’ revision3
Hepatic metastases in ovarian cancer3
Quest for an accurate and reproducible prognostic biomarker of severe acute pancreatitis: have we finally found it?3
Pancreatic cancer screening in high-risk individuals with genetic susceptibility3
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment3
Choledochoscopic photodynamic therapy combined with biliary stent implantation for the treatment of unresectable hilar cholangiocarcinoma3
Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer3
Robotic pancreaticoduodenectomy after the learning curve—a new hope3
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach3
In memoriam of Prof. Joseph Wan-yee Lau—our distinguished senior editorial board member3
Assessment of morbidity and mortality after liver transplantation for primary sclerosing cholangitis3
Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option3
Adjuvant therapy for intrahepatic carcinoma after surgical resection: chemotherapy and future perspectives3
The global burden of fatty liver disease: the major impact of China3
Giant accessory hepatic lobe accompanied by inflammatory pseudotumor3
Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation3
The role of B cells in metabolic (dysfunction)-associated fatty liver disease3
Optimizing venous outflow reconstruction for V5 & V8 in right-lobe living-donor liver transplantation: “half-circumferential anastomosis” using autologous vein grafts3
Surgical treatment strategies for multifocal hepatocellular carcinomas3
Predicting early graft loss in pancreas transplantation using novel imaging techniques: are we there yet?2
β-cryptoxanthin and fatty liver disease: new insights2
Liver anatomy by Francis Glisson2
Long-term normothermic machine perfusion of fatty livers: towards transplanting untransplantable livers?2
Anatomical study of the paracaval branch of the caudate lobe: implications of paracaval portion-preserving right hepatectomy for donors with marginal remnant liver volume2
Time-restricted feeding: what we have done and what more we can do?2
Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future2
Radiofrequency ablation for colorectal liver metastases: an evolving alternative or complement to resection?2
Hepatoid adenocarcinoma of the rectal2
Rare case of leiomyomatosis peritonealis disseminata with hepatic involvement2
Role of non-invasive tests in the management of resectable hepatocellular carcinoma: future directions2
The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment2
Hepatectomy guided by the diseased bile duct and hepatic vein for hepatolithiasis2
The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”?2
Is FOLFOX-HAIC superior to transarterial chemoembolization in treating large hepatocellular carcinoma?2
Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries2
Positive pancreatic neck margins—a telltale sign of complex biology2
Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective2
Pancreatic carcinoma disguised as type 1 autoimmune pancreatitis with a mass-forming appearance: a clinical dilemma2
Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure2
Application of liver transplant techniques in complex liver surgery: modified techniques and preliminary results of complex liver resection using in-situ hypothermic portal perfusion without venovenou2
The role of MRI in modifying surgical management of colorectal liver metastases: a lesson from the CAMINO trial2
Effects of exercise and nutrition in improving sarcopenia in liver cirrhosis patients: a systematic review and meta-analysis2
Primary tumor location and KRAS mutation: key prognostic factors in surgically treated colorectal liver metastases2
Continuous normothermic machine perfusion of donor livers in the United States: the challenging road from the trial-world into the real-world2
Short- and long-term outcomes of laparoscopic versus open resection of perihilar cholangiocarcinoma: a propensity score-based analysis2
Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis2
Improving outcomes of patients with severe respiratory and circulatory failure following living donor liver transplantation: efficacy of extracorporeal membrane oxygenation2
Tract hemostasis using radiofrequency ablation for hepatic arterial bleeding after percutaneous transhepatic portal embolization2
The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study2
James Hogarth Pringle and his time-honored maneuver2
Pancreatic exocrine insufficiency guidelines: more questions than answers!2
A novel nomogram for predicting the prognosis of hepatocellular carcinoma patients following immune checkpoint inhibitors treatment beyond progression: a single center study based on Chinese populatio2
Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score2
East meets West: what opportunities arise in comparing international guidelines for management of cirrhosis?2
Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies2
Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: far from a clinical consensus2
A European expert consensus surgical technique description for robotic hepatectomy2
Evolving concepts in the management of hepatocellular carcinoma: from ‘stage hierarchy’ to the ‘multiparametric therapeutic hierarchy’ approach2
Alternatives to left lateral sector in paediatric liver transplantation—a systematic review on monosegmental and reduced grafts2
Evaluating liver resection outcomes post Y90 TARE with personalized dosimetry in intermediate or advanced hepatocellular carcinoma: a focus on surgical and biliary complications2
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights2
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals2
Robotic-assisted cholecystectomy: stepping stone to expertise or vogue?2
A combined pre- and intra-operative nomogram in evaluation of degrees of liver cirrhosis predicts post-hepatectomy liver failure: a multicenter prospective study2
Update on herbal and dietary supplement-induced liver injury: current gaps and future directions2
Cystic liver lesions: from diagnosis to recognition of complications and when to treat2
Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial2
Advancing prognostic models in salvage liver transplantation2
Based on the results of a large retrospective study comparing laparoscopic liver surgery and robotic liver surgery, is it time for the next step in robotic liver resection?2
Liver transplantation for colorectal liver metastasis: the exception, not the rule2
Liver resection, and technical advances to mitigate post-hepatectomy liver failure2
Genomic alterations in hepatocellular carcinoma and their clinical application to genomic medicine2
More accurate reporting of surgical techniques would be SUPER2
Body mass index and ampulla of Vater cancer incidence and survival: a cohort study of 1.7 million Norwegians2
Clinical feasibility of modified extended left hemihepatectomy in advanced perihilar cholangiocarcinoma2
0.11918592453003